A Study of the LVIVO-TaVec122 Product in Subjects With Relapsed/Refractory B-cell Malignancies
Clinical trial NCT07628582 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07628582
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-15
- Primary completion
- 2028-10-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.